A list of ProgStar updates, news and publications, as well as publications relevant to STGD by ProgStar study investigators.
For a list of all published ProgStar study reports please click here.
A video of a presentation by HPN Scholl (including ppt slides ) and a summary of the main ProgStar study results may be found here.
An expert panel of retina specialists of the American Academy of Ophthalmology awarded a paper from the ProgStar study group as the one that they rated most highly. The Read More…
To describe the yearly progression rate of atrophic lesions in the retrospective Progression of Stargardt Disease study. Read More…
To estimate the yearly rate of change of best-corrected visual acuity (BCVA) and the risk of loss 1 line or more over 1 year and to identify risk factors for BCVA loss in patients with Stargardt disease (STGD1). Read More…
These findings suggest microperimetry allows a more comprehensive assessment of the function of the central retina, and it may serve as an outcome measure in future clinical trials for Stargardt disease and other macular diseases. Read More…
To examine the incidence of atrophic lesions in patients with Stargardt disease. Read More…
To compare different metrics and acquisition modes of fixation stability as a new visual function biomarker in a large cohort of patients with ABCA4-related Stargardt disease from the multicenter prospective ProgStar study. Read More…
To investigate the impact of areas of decreased fundus autofluorescence (AF) on visual acuity (VA) in molecularly confirmed Stargardt disease (STGD1) with recent symptom onset, and investigate the association between these structural and functional measures over time. Read More…
To determine fixation location and fixation stability in Stargardt disease (STGD1) and their association with best-corrected visual acuity (BCVA). Read More…
In individual patients, disease stage will determine whether the therapeutic strategy should comprise photoreceptor cell rescue to delay or arrest vision loss or retinal replacement for vision restoration. Read More…
To examine the association between characteristics of Stargardt disease and visual acuity (VA), to estimate the longitudinal rate of VA loss, and to identify risk factors for VA loss. Read More…